Toshihide Shima

4.2k total citations
70 papers, 1.8k citations indexed

About

Toshihide Shima is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Toshihide Shima has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 31 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Toshihide Shima's work include Liver Disease Diagnosis and Treatment (42 papers), Liver Diseases and Immunity (15 papers) and Hepatitis C virus research (14 papers). Toshihide Shima is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Liver Diseases and Immunity (15 papers) and Hepatitis C virus research (14 papers). Toshihide Shima collaborates with scholars based in Japan, United States and France. Toshihide Shima's co-authors include Takeshi Okanoue, Kohichiroh Yasui, Harold M. Swartz, Miwa Kawanaka, Antonella Stroppolo, R. Gerbasi, Tadeusz Sarna, Luigi Zecca, Yoshito Itoh and Masayuki Mizuno and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Applied Physiology.

In The Last Decade

Toshihide Shima

66 papers receiving 1.8k citations

Peers

Toshihide Shima
C. Candelaresi Italy
Yukinori Koyama Japan
Aina Rodríguez‐Vilarrupla Spain
Prasanna K. Santhekadur India
Banumathi K. Cole United States
Ryan G. Holzer United States
Réjane Paumelle France
Yanqiao Zhang United States
Yaxi Chen China
Hirohito Yoneyama Japan
C. Candelaresi Italy
Toshihide Shima
Citations per year, relative to Toshihide Shima Toshihide Shima (= 1×) peers C. Candelaresi

Countries citing papers authored by Toshihide Shima

Since Specialization
Citations

This map shows the geographic impact of Toshihide Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihide Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihide Shima more than expected).

Fields of papers citing papers by Toshihide Shima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihide Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihide Shima. The network helps show where Toshihide Shima may publish in the future.

Co-authorship network of co-authors of Toshihide Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihide Shima. A scholar is included among the top collaborators of Toshihide Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihide Shima. Toshihide Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seko, Yuya, Kanji Yamaguchi, Toshihide Shima, et al.. (2024). Prognostic performance of a two‐step method using the Fibro‐Scope system for metabolic dysfunction‐associated steatotic liver disease. Hepatology Research. 55(2). 211–218. 1 indexed citations
2.
Seko, Yuya, Kanji Yamaguchi, Toshihide Shima, et al.. (2024). Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver‐Related Events in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Liver International. 45(4). e16124–e16124. 6 indexed citations
3.
Okanoue, Takeshi, Kanji Yamaguchi, Toshihide Shima, et al.. (2023). Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology Research. 53(12). 1213–1223. 3 indexed citations
4.
Seko, Yuya, Kanji Yamaguchi, Toshihide Shima, et al.. (2023). The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study. Liver International. 43(10). 2210–2219. 21 indexed citations
5.
Toyoda, Hidenori, Satoshi Yasuda, Akio Moriya, et al.. (2022). Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy. Journal of Infection and Chemotherapy. 28(9). 1231–1234. 1 indexed citations
6.
Sato, Masaya, Masatoshi Akamatsu, Toshihide Shima, et al.. (2022). Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. The American Journal of Gastroenterology. 118(8). 1365–1372. 9 indexed citations
7.
Umemura, Atsushi, S Umemura, Seita Kataoka, et al.. (2021). Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. Cancers. 13(7). 1515–1515. 17 indexed citations
8.
Umemura, Atsushi, Seita Kataoka, Aya Takahashi, et al.. (2021). Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress. Frontiers in Oncology. 11. 758549–758549. 9 indexed citations
9.
Sumida, Yoshio, Toshihide Shima, Yasuhide Mitsumoto, et al.. (2020). Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. International Journal of Molecular Sciences. 21(12). 4337–4337. 22 indexed citations
10.
Itoh, Yoshito, Yuya Seko, Toshihide Shima, et al.. (2018). Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study. Hepatology Research. 48(13). 1099–1107. 21 indexed citations
11.
Fujii, Hideki, Atsushi Umemura, Taichiro Nishikawa, et al.. (2017). Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions. World Journal of Hepatology. 9(25). 1064–1064. 5 indexed citations
12.
Koyama, Noriyuki, Tomoko Yamazaki, Yasuhide Mitsumoto, et al.. (2017). Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma. Journal of Gastroenterology. 53(6). 770–779. 26 indexed citations
13.
Toyoda, Hidenori, Takashi Kumada, Toshifumi Tada, et al.. (2016). Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B. Journal of Hepatology. 66(3). 521–527. 22 indexed citations
14.
Sawai, Naoki, Ryusuke Kato, Hiroaki Hashimoto, et al.. (2012). [A case of HER2-positive and AFP-producing gastric cancer successfully treated by trastuzumab/docetaxel/S-1 combination therapy].. PubMed. 39(13). 2541–4. 6 indexed citations
15.
Yasui, Kohichiroh, Etsuko Hashimoto, Yasuji Komorizono, et al.. (2011). Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. 9(5). 428–433. 319 indexed citations
16.
Park, Hyohun, Toshihide Shima, Kanji Yamaguchi, et al.. (2010). Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. Journal of Gastroenterology. 46(1). 101–107. 153 indexed citations
17.
Umemura, Atsushi, et al.. (2009). A case report of successful treatment with a cholesterol absorption inhibitor for decompensated burned-out NASH. Kanzo. 50(9). 532–539. 1 indexed citations
18.
Park, Hyohun, Akihito Ishigami, Toshihide Shima, et al.. (2009). Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. Journal of Gastroenterology. 45(4). 426–434. 38 indexed citations
19.
20.
Nakashima, Toshiaki, Atsushi Sano, Toshihide Shima, et al.. (1990). Unusual Trihydroxy Bile Acids in the Urine of Patients Treated With Chenodeoxycholate, Ursodeoxycholate or Rifampicin and Those With Cirrhosis. Hepatology. 11(2). 255–260. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Candelaresi Breakdown of academic impact, for papers by Yukinori Koyama Breakdown of academic impact, for papers by Aina Rodríguez‐Vilarrupla Breakdown of academic impact, for papers by Prasanna K. Santhekadur Breakdown of academic impact, for papers by Banumathi K. Cole Breakdown of academic impact, for papers by Ryan G. Holzer Breakdown of academic impact, for papers by Réjane Paumelle Breakdown of academic impact, for papers by Yanqiao Zhang Breakdown of academic impact, for papers by Yaxi Chen Breakdown of academic impact, for papers by Hirohito Yoneyama
Rankless by CCL
2026